Search results
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC· 1 hour agoEli Lilly shares dropped nearly 3%, while Novo Nordisk's U.S.-traded shares fell more than 1%. Novo ...
Amgen Knocks Novo Nordisk's Ozempic Stock Rally
The Wall Street Journal· 2 hours agoAmgen’s progress on its experimental weight-loss drug offered investors a reminder that Novo Nordisk isn’t the only game in town. Novo
Novo Nordisk AS Stock Price Today | BVMF N1VO34 - Investing.com Canada
Investing.com· 2 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
Barrons.com· 23 hours agoFEATURE Novo Nordisk shares slipped on Thursday after sales of the company’s weight-loss drug Wegovy...
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
CNBC· 3 hours agoShares of Danish pharmaceutical giant Novo Nordisk slid 4% on Friday, extending a 2.7% loss on...
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 55 minutes agoShares are working their way toward their record high at 329.72, achieved on Feb. 5. Amgen Stock:...
AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company?
InvestorPlace· 1 hour agoAmgen (NASDAQ:AMGN) stock is trending and up about 12% as of this writing. The shares are rallying...
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Motley Fool via Yahoo Finance· 5 hours agoAnd as that happens, investors may be willing to pay a higher price for Novo Nordisk's stock. Novo ...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 24 hours ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
Novo Nordisk Dips As Wegovy Sales Double, But Miss Forecasts
Investor's Business Daily· 20 hours agoNovo stock dipped Thursday after sales of Wegovy nearly doubled, but missed.